The GlaxoSmithKline controversy opened the doors of investigation about the misconduct happening in the pharmaceutical industry.
GlaxoSmithKline
Breaking News
China's Commerce Ministry confident probe on drugmaker GlaxoSmithKline won't mar investor confidence
China remains confident that the ongoing investigations for alleged bribery of GSK execs in its China division won't mar investor confidence.
GlaxoSmithKline's plans to raise stakes in GSK Consumer Nigeria on hold after shareholder opposition.
GlaxoSmithKline Plc's 20% increase in sales was currently in focus due to Public Security Ministry's accusations on bribery and sexual favors.
Sources revealed that AG Barr could be buying GlaxoSmithKline's Ribena and Lucozade brands.
GSK was offered a formal takeover bid priced more than a billion pounds for its soft drink brand Lucozade and Ribena by Blackstone and Lion Capital.
Bids, mergers, acquisitions and disposals involving European, U.S. and Asian companies.
1 2
Subscribe to VCpost newsletter
Most Popular
- IRS Scrambles to Address Huge Gap in Audit Rates Between Black, Other Taxpayers
- Hims & Hers CEO Responds to Backlash After Facing Stock Plunge Over Comments Praising Anti-Israel Protesters
- Americans Brace for Another Round of Higher Housing Costs, NY Fed Survey Shows
- Social Security and Medicare Get Boost From Stronger US Economy, But Funds Expected to Run Short in 2035
- Biden’s Economic Advisor Jared Bernstein Awkwardly Explains How Money Works
- Xi Jinping Urges France to Resist 'New Cold War' Amid EU's Shift Towards US Alliance
- Over 1,000 Denver International Airport Flights Delayed Over Wind Gusts
- EU is Set to Intensify Sanctions Against Russia Amid Report Kremlin Plots Sabotage Attack